Home

ubiquitintagged

Ubiquitin-tagged refers to proteins that have been covalently modified by the small regulatory protein ubiquitin. This modification is typically accomplished through an enzymatic cascade involving ubiquitin-activating enzyme (E1), ubiquitin-conjugating enzyme (E2), and ubiquitin ligase (E3), which attach ubiquitin to a substrate’s lysine residue via an isopeptide bond. The process can yield a single ubiquitin moiety (monoubiquitination) or polymeric chains (polyubiquitination) with different linkage types that influence cellular outcomes. The most common chains are linked through lysine 48 (K48), often signaling proteasomal degradation, and lysine 63 (K63), which is involved in signaling, endocytosis, and DNA repair; linear (M1) chains also participate in various signaling pathways.

Proteins can be ubiquitin-tagged temporarily; deubiquitinating enzymes (DUBs) remove ubiquitin, reversing the signal. Ubiquitin tagging affects

Detection and study of ubiquitin-tagged proteins employ immunoblotting with anti-ubiquitin antibodies, mass spectrometry to identify modification

The term ubiquitin-tagged is used broadly to describe any substrate carrying covalently attached ubiquitin, regardless of

protein
fate:
targeting
to
the
26S
proteasome
for
degradation,
altering
subcellular
localization,
modulating
activity,
or
mediating
interactions
with
other
proteins.
Beyond
quality
control
for
misfolded
proteins,
ubiquitination
participates
in
diverse
processes
such
as
cell
cycle
control,
DNA
damage
response,
and
membrane
trafficking.
sites
and
chain
types,
and
enrichment
techniques,
including
tandem
ubiquitin
binding
entities.
Abnormal
ubiquitin
tagging
is
implicated
in
diseases
such
as
cancer,
neurodegeneration,
and
inflammatory
disorders.
chain
type
or
functional
outcome.